Featured post

Blood & Tissue Serology Services launch

 

Grand launch of Blood & Tissue Serology Services to be held on Wednesday 11th February 2015 within our Rochdale facility.

 

Latest News

Holdings in Company

29 Jan 2015

The attached TR1 notification relates to the shareholding in Source BioScience held by Oryx International Growth Fund Limited which now stands at 38,767,620 shares, representing 12.36% of the Company’s ordinary share capital.

Read more »

Holdings in Company

29 Jan 2015

The attached TR1 notification relates to the shareholding in Source BioScience held by Richard Griffiths and his controlled undertakings, which now stands at 28,869,315 shares, representing 9.21% of the Company’s ordinary share capital.

Read more »

Holdings in Company

23 Jan 2015

The attached TR1 notification relates to the shareholding in Source BioScience held by Henderson Global Investors which now stands at 53,816,631 shares, representing 17.16% of the Company’s ordinary share capital.

Read more »

Holdings in Company

23 Jan 2015

The attached TR1 notification relates to the shareholding in Source BioScience held by Oryx International Growth Fund Limited which now stands at 36,367,620 shares, representing 11.6% of the Company’s ordinary share capital.

Read more »

Holdings in Company

22 Jan 2015

The attached TR1 notification relates to the shareholding in Source BioScience held by Oryx International Growth Fund Limited which now stands at 28,617,620 shares, representing 9.13% of the Company’s ordinary share capital.

Read more »

Trading Update

21 Jan 2015

Source BioScience plc today announces an update on its trading performance for the year ended 31 December 2014.

Read more »